Thiem D Phan

Array ( [id] => 4873959 [patent_doc_number] => 20080200693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Derivatives of Aryl (or Heteroaryl) Azolylcarbinols (in Particular Cizolirtin Citrate) for the Treatment of Opioid Addiction' [patent_app_type] => utility [patent_app_number] => 11/574721 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9831 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200693.pdf [firstpage_image] =>[orig_patent_app_number] => 11574721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887620 [patent_doc_number] => 20080261952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Aryl Urea Derivatives for Treating Obesity' [patent_app_type] => utility [patent_app_number] => 11/660405 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20870 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261952.pdf [firstpage_image] =>[orig_patent_app_number] => 11660405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337353 [patent_doc_number] => 20090053817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'FIXED CHARGE REAGENTS' [patent_app_type] => utility [patent_app_number] => 11/573362 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5853 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053817.pdf [firstpage_image] =>[orig_patent_app_number] => 11573362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225614 [patent_doc_number] => 20070254881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Pyrazole Derivative' [patent_app_type] => utility [patent_app_number] => 11/573098 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90523 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254881.pdf [firstpage_image] =>[orig_patent_app_number] => 11573098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267282 [patent_doc_number] => 07566808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Management of ophthalmologic disorders, including macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/199594 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 63 [patent_no_of_words] => 43141 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566808.pdf [firstpage_image] =>[orig_patent_app_number] => 11199594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895656 [patent_doc_number] => 20060004195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Alpha,beta-unsaturated esters and acids by stereoselective dehydration' [patent_app_type] => utility [patent_app_number] => 11/168938 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75629 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004195.pdf [firstpage_image] =>[orig_patent_app_number] => 11168938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978518 [patent_doc_number] => 20050288236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Substituted fullerene formulations and their use in ameliorating oxidative stress diseases or inhibiting cell death' [patent_app_type] => utility [patent_app_number] => 11/158915 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13772 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288236.pdf [firstpage_image] =>[orig_patent_app_number] => 11158915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813869 [patent_doc_number] => 07414143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman' [patent_app_type] => utility [patent_app_number] => 11/158856 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414143.pdf [firstpage_image] =>[orig_patent_app_number] => 11158856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738520 [patent_doc_number] => 08410289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Spirocyclic 3\'-alkoxytetramic acids and-tetronic acids' [patent_app_type] => utility [patent_app_number] => 11/630246 [patent_app_country] => US [patent_app_date] => 2005-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48699 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11630246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4585357 [patent_doc_number] => 07851637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners' [patent_app_type] => utility [patent_app_number] => 11/156364 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 52235 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851637.pdf [firstpage_image] =>[orig_patent_app_number] => 11156364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189688 [patent_doc_number] => 08183386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Phenylnaphthylimidazole compound and usage of the same' [patent_app_type] => utility [patent_app_number] => 11/629179 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9055 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183386.pdf [firstpage_image] =>[orig_patent_app_number] => 11629179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4581443 [patent_doc_number] => 07834196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Process for the preparation of N-alkyl-pyrrolidones' [patent_app_type] => utility [patent_app_number] => 11/570179 [patent_app_country] => US [patent_app_date] => 2005-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3348 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834196.pdf [firstpage_image] =>[orig_patent_app_number] => 11570179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159377 [patent_doc_number] => 20070172421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Substituted pyrrolidine-2-ones' [patent_app_type] => utility [patent_app_number] => 11/569164 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23022 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172421.pdf [firstpage_image] =>[orig_patent_app_number] => 11569164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853056 [patent_doc_number] => 07378441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Resistance-repellent retroviral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/124056 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 3 [patent_no_of_words] => 28796 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378441.pdf [firstpage_image] =>[orig_patent_app_number] => 11124056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835321 [patent_doc_number] => 20060247152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Substituted fullerenes and their use as inhibitors of cell death' [patent_app_type] => utility [patent_app_number] => 11/120168 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12247 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247152.pdf [firstpage_image] =>[orig_patent_app_number] => 11120168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070134 [patent_doc_number] => 20050245519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Substituted morpholine compounds for the treatment of central nervous system disorders' [patent_app_type] => utility [patent_app_number] => 11/119210 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32664 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245519.pdf [firstpage_image] =>[orig_patent_app_number] => 11119210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046180 [patent_doc_number] => 20050250775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 11/117896 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 44975 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250775.pdf [firstpage_image] =>[orig_patent_app_number] => 11117896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777380 [patent_doc_number] => 20060106020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Tetracyclic inhibitors of Janus kinases' [patent_app_type] => utility [patent_app_number] => 11/115702 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59552 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106020.pdf [firstpage_image] =>[orig_patent_app_number] => 11115702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952939 [patent_doc_number] => 20050228034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Tetrahydro-indazole cannabinoid modulators' [patent_app_type] => utility [patent_app_number] => 11/087943 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36381 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20050228034.pdf [firstpage_image] =>[orig_patent_app_number] => 11087943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4585306 [patent_doc_number] => 07851634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => '5-amino 4-hydroxy-7-(1H-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension' [patent_app_type] => utility [patent_app_number] => 10/593460 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17576 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851634.pdf [firstpage_image] =>[orig_patent_app_number] => 10593460 [rel_patent_id] =>[rel_patent_doc_number] =>)